CN102432523A - Method for synthesizing 3-hydroxy-3-arylindole-2-one derivative - Google Patents

Method for synthesizing 3-hydroxy-3-arylindole-2-one derivative Download PDF

Info

Publication number
CN102432523A
CN102432523A CN2011102821428A CN201110282142A CN102432523A CN 102432523 A CN102432523 A CN 102432523A CN 2011102821428 A CN2011102821428 A CN 2011102821428A CN 201110282142 A CN201110282142 A CN 201110282142A CN 102432523 A CN102432523 A CN 102432523A
Authority
CN
China
Prior art keywords
hydroxyl
copper
hetero
ketone derivatives
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011102821428A
Other languages
Chinese (zh)
Other versions
CN102432523B (en
Inventor
陈久喜
刘妙昌
高文霞
张吉磊
吴华悦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wenzhou University
Original Assignee
Wenzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wenzhou University filed Critical Wenzhou University
Priority to CN 201110282142 priority Critical patent/CN102432523B/en
Publication of CN102432523A publication Critical patent/CN102432523A/en
Application granted granted Critical
Publication of CN102432523B publication Critical patent/CN102432523B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention discloses a method for synthesizing a 3-hydroxy-3-arylindole-2-one derivative shown as a structural formula (I), which comprises the following steps of: fully reacting raw materials such as an isatin compound shown as a structural formula (II) and arylboric acid shown as a structural formula (III) in an inert organic solvent in the presence of a copper catalyst, a nitrogen-containing bidentate ligand and an alkaline compound, and separating and purifying reaction liquid after the reaction is finished to obtain the 3-hydroxy-3-arylindole-2-one derivative, wherein the copper catalyst is one or any combination of copper trifluoromethanesulfonate, copper acetylacetonate, copper acetate, cuprous iodide, copper bromide, copper fluoride and copper chloride. The method is high in implementation value and good in social benefit and economic benefit.

Description

The compound method of a kind of 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives
(1) technical field
The present invention relates to the chemical synthesis process of a kind of 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives.
(2) background technology
3-hydroxyl-3-(hetero) aryl indole-2-ketone compounds is one type of compound with good biological activity and pharmacologically active; Be widely used in the synthetic of agricultural chemicals, medicine; Have very high practical value, its verivate is being brought into play active effect at aspects such as anticancer, anti-inflammatory, treatment hematologic diseases.
In the prior art; (as: the Angew.Chem.Int.Ed.2011 that has; 50,7620) synthesize 3-hydroxyl-3-(hetero) aryl indole-2-one derivative compounds with intramolecular cyclization reaction, this method is to utilize metal palladium catalyst to be configured to ring structure; To the strict of the structure of reaction substrate and be difficult to obtain, and catalyst system therefor is relatively more expensive.Have (like J.Am.Chem.Soc.2004; 126,12888 and Bioorg.Med.Chem.Lett.2010,20; 3103) synthesize 3-hydroxyl-3-(hetero) aryl indole-2-ketone compounds with organometallic reagent (like Grignard reagent or organolithium reagent) as aromatic yl reagent-ing; This method is a nucleophilicity of utilizing organometallic reagent stronger, but because the toxicity of organometallic reagent and to the restriction of functional group, and the shortcomings such as sensitivity of empty G&W are all being limited being widely used of this method.
To the above unfavorable factor of considering, therefore existing method is improved, develop a kind of efficient, cheapness, 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives compound method has very big economic benefit and social benefit easily.
(3) summary of the invention
The purpose of this invention is to provide a kind of technology rationally, hypotoxicity, reaction conditions is gentle, reaction yield is high and the chemical synthesis process of the 3-of good product quality hydroxyl-3-(hetero) aryl indole-2-ketone derivatives.
For realizing the foregoing invention purpose, the present invention adopts following technical scheme:
A kind of structure is suc as formula the compound method of the 3-hydroxyl shown in (I)-3-(hetero) aryl indole-2-ketone derivatives; Said method comprises the following steps: that be raw material suc as formula isatin compounds shown in (II) and structure suc as formula the aryl boric acid shown in (III) with structure; Fully reaction in inert organic solvents in the presence of copper catalyst, nitrogenous bitooth ligand and basic cpd, reaction finishes afterreaction liquid and obtains described 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives through separation and purification; Described copper catalyst is selected from following a kind of or any several kinds combination: copper trifluoromethanesulfcomposite, acetylacetone copper, neutralized verdigris, cuprous iodide, cupric bromide, cupric fluoride, cupric chloride;
Figure BDA0000093176530000021
Formula (I), (II) or (III) in, R 1And R 2Independently be selected from one of following separately: the alkyl of hydrogen, C1~C8, the alkoxyl group of C1~C8, allyl group, benzyl, hydrocinnamyl, halogen; R 3Be selected from one of following: phenyl, naphthyl, substituted-phenyl, the substituting group of said substituted-phenyl are the alkyl of C1~C8, alkoxyl group, trifluoromethyl, halogen, nitro or the phenyl of C1~C8.
Further, described R 1Be preferably one of following: the alkyl of hydrogen, C1~C8, C1~C8 alkoxyl group, halogen, one of more preferably following: hydrogen, methyl, methoxyl group, halogen further are preferably one of following: hydrogen, methyl, methoxyl group, chlorine.
Further, described R 2One of be preferably one of following: the alkyl of C1~C8, allyl group, benzyl, hydrocinnamyl, more preferably following: methyl, normal-butyl, n-hexyl, allyl group, benzyl, hydrocinnamyl.
Further, described R 3Be preferably one of following: phenyl, substituted-phenyl, the substituting group of said substituted-phenyl are selected from one of following: the alkyl of C1~C8, the alkoxyl group of C1~C8, trifluoromethyl, halogen, nitro or phenyl; The alkyl of described C1~C8 is preferably methyl, and the alkoxyl group of described C1~C8 is preferably methoxyl group.
It is one of following that nitrogenous bitooth ligand of the present invention can be selected from: a water phenanthroline, 4,7-dimethyl-phenanthroline, dipyridyl, 4,4 '-dimethyl--2,2 '-dipyridyl; Be preferably a water phenanthroline.
Basic cpd of the present invention can be like mineral alkalis such as yellow soda ash, salt of wormwood, cesium carbonate, Quilonum Retard, sodium hydroxide, Pottasium Hydroxide, Lithium Hydroxide MonoHydrate, potassiumphosphate, Potassium monofluoride, Repone K, lithium fluoride, lithiumbromide, sodium-acetate, potassium tert.-butoxides; Also can be organic basess such as triethylamine, urotropine; It also can be the mixture of above-mentioned mineral alkali and organic bases.
The organic solvent of inert organic solvents according to the invention for not reacting with reactant; Usually can select alkanes, halogenated hydrocarbon, the N of C1~C8 for use; N, a kind of or any several kinds combination in-dimethylformamide class, ester class, alcohols, ethers, ketone, the nitrile solvents, preferred methylene dichloride.The quality consumption of said inert organic solvents is 1~35 times of said isatin compounds quality, is preferably 15~25 times.
Copper catalyst of the present invention is preferably copper trifluoromethanesulfcomposite or acetylacetone copper.
The molar ratio of isatin compounds according to the invention and aryl boric acid, mantoquita, nitrogenous bitooth ligand and basic cpd is 1.0: 1.0~6.0: 0.01~1.0: 0.01~1.0: 1.0~5.0; Be preferably 1.0: 2.0~4.0: 0.05~0.1: 0.05~0.1: 2.0~3.5, more preferably 1.0: 3.0~4.0: 0.05~0.1: 0.05~0.1: 2.5~3.5.
Among the present invention, temperature of reaction is 30~150 ℃, is preferably 45~100 ℃; Reaction times is preferably 24~48h generally at 5~72h.
Separation and purification of the present invention can be adopted following method: the gained reaction solution steams earlier and desolventizes; Add saturated sodium bicarbonate again, separate and get organic layer, the rotation evaporate to dryness; Bullion is used ethyl alcohol recrystallization, is described 3-hydroxyl-3-Phenylindole-2-ketone derivatives after the drying.
The concrete chemical synthesis process of described 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives of recommending of the present invention carries out according to following steps: under the room temperature, be that 1.0: 3.0~4.0: 0.05~0.1: 0.05~0.1: 2.5~3.5 isatin compounds, aryl boric acid, copper catalyst, nitrogenous bitooth ligand and basic cpd add in the reaction kettle with mol ratio, after the inert organic solvents dissolving; Be warming up to 30-150 ℃; Reaction 5h-72h is to reacting completely, and steaming earlier desolventizes, and adds saturated sodium bicarbonate again; Separate and get organic layer; The rotation evaporate to dryness, bullion is used ethyl alcohol recrystallization, is described 3-hydroxyl-3-Phenylindole-2-ketone derivatives after the drying.
The present invention compared with prior art, its beneficial effect is mainly reflected in: 1. reaction yield is higher relatively, good product quality; 2. operational path is advanced rationally, reaction conditions is gentle; 3. the few and low price of catalyst levels; So the present invention has bigger implementary value and economic results in society.
(4) embodiment
Below in conjunction with specific embodiment the present invention is described further, but protection scope of the present invention is not limited in this:
Embodiment 1:
N-methyl-isatin, phenylo boric acid, copper trifluoromethanesulfcomposite, a water phenanthroline, Lithium Hydroxide Monohydrate are 1.0: 2.0: 0.05 with the amount of substance ratio: feed intake N-methyl-isatin 16.1g (0.1mol) at 0.1: 3.0; Phenylo boric acid 24.4g (0.2mol); Copper trifluoromethanesulfcomposite 1.8g (0.005mol); One water phenanthroline 2.0g (0.01mol); Lithium Hydroxide Monohydrate 12.6g (0.3mol); Organic solvent is YLENE 241.5g, and its total consumption is 15 times of N-methyl-isatin quality.
N-methyl-isatin, phenylo boric acid, copper trifluoromethanesulfcomposite, a water phenanthroline, Lithium Hydroxide Monohydrate are dropped in the reaction kettle, add xylene soluble, temperature of reaction is 100 ℃, and afterreaction finished in 48 hours.
Reaction finishes the back underpressure distillation and reclaims organic solvent, and the solid that remains in the reaction flask gets white solid through the ethyl alcohol recrystallization of crossing with the calcium chloride drying, promptly gets N-methyl-3-hydroxyl-3-Phenylindole-2-ketone 14.8g, yield 62%, purity 98.1%.
Nuclear magnetic resonance spectrum (Bruke): 1H NMR (CDCl 3, 500MHz): δ (ppm)=3.17 (3H, s), 3.40 (1H, s), 6.83 (1H, d, J=10Hz), 7.02 (1H, t, J=10Hz), 7.18-7.32 (7H, m); 13C NMR (CDCl 3, 125MHz): δ (ppm)=26.5,77.9,108.7,123.5,124.9,125.3,128.3,128.6,129.9,131.6,140.1,143.5,177.5.
Embodiment 2:
N-methyl-isatin, phenylo boric acid, copper trifluoromethanesulfcomposite, 4,4 '-dimethyl--2,2 '-dipyridyl, Lithium Hydroxide Monohydrate are 1.0: 2.0: 0.05 with the amount of substance ratio: feed intake N-methyl-isatin 16.1g (0.1mol) at 0.1: 3.0; Phenylo boric acid 24.4g (0.2mol); Copper trifluoromethanesulfcomposite 0.92g (0.005mol); 4,4 '-dimethyl--2,2 '-dipyridyl 2.08g (0.01mol); Lithium Hydroxide Monohydrate 12.6g (0.3mol); Organic solvent is YLENE 241.5g, and its total consumption is 15 times of N-methyl-isatin quality.
All the other are with embodiment 1, products obtained therefrom N-methyl-3-hydroxyl-3-Phenylindole-2-ketone 11.9g, yield 50%, purity 98.5%.
Embodiment 3:
N-methyl-isatin, phenylo boric acid, copper trifluoromethanesulfcomposite, a water phenanthroline, cesium carbonate are 1.0: 2.0: 0.05 with the amount of substance ratio: feed intake N-methyl-isatin 16.1g (0.1mol) at 0.1: 3.0; Phenylo boric acid 24.4g (0.2mol); Copper trifluoromethanesulfcomposite 1.8g (0.005mol); One water phenanthroline 2.0g (0.01mol); Cesium carbonate 97.8g (0.3mol); Organic solvent is YLENE 241.5g, and its total consumption is 15 times of N-methyl-isatin quality.
All the other are with embodiment 1, products obtained therefrom N-methyl-3-hydroxyl-3-Phenylindole-2-ketone 13.9g, yield 58%, purity 98.4%.
Embodiment 4:
N-methyl-isatin, phenylo boric acid, cuprous iodide, a water phenanthroline, Lithium Hydroxide Monohydrate are 1.0: 2.0: 0.05 with the amount of substance ratio: feed intake N-methyl-isatin 16.1g (0.1mol) at 0.1: 3.0; Phenylo boric acid 24.4g (0.2mol); Cuprous iodide 0.95g (0.005mol); One water phenanthroline 2.0g (0.01mol); Lithium Hydroxide Monohydrate 12.6g (0.3mol); Organic solvent is YLENE 241.5g, and its total consumption is 15 times of N-methyl-isatin quality.
All the other are with embodiment 1, products obtained therefrom N-methyl-3-hydroxyl-3-Phenylindole-2-ketone 13.6g, yield 57%, purity 97.9%.
Embodiment 5:
N-methyl-isatin, phenylo boric acid, cupric bromide, a water phenanthroline, Lithium Hydroxide Monohydrate are 1.0: 2.0: 0.05 with the amount of substance ratio: feed intake N-methyl-isatin 16.1g (0.1mol) at 0.1: 3.0; Phenylo boric acid 24.4g (0.2mol); Copper trifluoromethanesulfcomposite 1.8g (0.005mol); One water phenanthroline 2.0g (0.01mol); Lithium Hydroxide Monohydrate 12.6g (0.3mol); Organic solvent is toluene 241.5g, and its total consumption is 15 times of N-methyl-isatin quality.
All the other are with embodiment 1, products obtained therefrom N-methyl-3-hydroxyl-3-Phenylindole-2-ketone 13.9g, yield 58%, purity 99.2%.
Embodiment 6:
N-methyl-isatin, phenylo boric acid, copper trifluoromethanesulfcomposite, a water phenanthroline, Lithium Hydroxide Monohydrate are 1.0: 2.0: 0.05 with the amount of substance ratio: feed intake N-methyl-isatin 16.1g (0.1mol) at 0.1: 3.0; Phenylo boric acid 24.4g (0.2mol); Copper trifluoromethanesulfcomposite 1.8g (0.005mol); One water phenanthroline 2.0g (0.01mol); Lithium Hydroxide Monohydrate 12.6g (0.3mol); Organic solvent is methylene dichloride 241.5g, and its total consumption is 15 times of N-methyl-isatin quality.
N-methyl-isatin, phenylo boric acid, copper trifluoromethanesulfcomposite, a water phenanthroline, Lithium Hydroxide Monohydrate are dropped in the reaction kettle, add methylene dichloride dissolving back sealing.Temperature of reaction is 80 ℃, and 48 hours finish.
Reaction finishes the back underpressure distillation and reclaims organic solvent, and the solid that remains in the reaction flask gets white solid through the ethyl alcohol recrystallization of crossing with the calcium chloride drying, promptly gets N-methyl-3-hydroxyl-3-Phenylindole-2-ketone 17.1g, yield 71%, purity 99%.
Embodiment 7:
N-methyl-isatin, phenylo boric acid, copper trifluoromethanesulfcomposite, a water phenanthroline, Lithium Hydroxide Monohydrate are 1.0: 2.0: 0.1 with the amount of substance ratio: feed intake N-methyl-isatin 16.1g (0.1mol) at 0.1: 3.0; Phenylo boric acid 24.4g (0.2mol); Copper trifluoromethanesulfcomposite 3.6g (0.01mol); One water phenanthroline 2.0g (0.01mol); Lithium Hydroxide Monohydrate 12.6g (0.3mol); Organic solvent is methylene dichloride 322g, and its total consumption is 20 times of N-methyl-isatin quality.
All the other are with embodiment 6, products obtained therefrom N-methyl-3-hydroxyl-3-Phenylindole-2-ketone 19.6g, yield 82%, purity 98.8%.
Embodiment 8:
N-methyl-isatin, phenylo boric acid, copper trifluoromethanesulfcomposite, a water phenanthroline, Lithium Hydroxide Monohydrate are 1.0: 3.0: 0.05 with the amount of substance ratio: feed intake N-methyl-isatin 16.1g (0.1mol) at 0.1: 3.0; Phenylo boric acid 36.6g (0.3mol); Copper trifluoromethanesulfcomposite 1.8g (0.005mol); One water phenanthroline 2.0g (0.01mol); Lithium Hydroxide Monohydrate 12.6g (0.3mol); Organic solvent is methylene dichloride 322g, and its total consumption is 20 times of N-methyl-isatin quality.
All the other are with embodiment 6, products obtained therefrom N-methyl-3-hydroxyl-3-Phenylindole-2-ketone 20.6g, yield 86%, purity 99.2%.
Embodiment 9:
N-methyl-isatin, phenylo boric acid, copper trifluoromethanesulfcomposite, a water phenanthroline, Lithium Hydroxide Monohydrate are 1.0: 4.0: 0.05 with the amount of substance ratio: feed intake N-methyl-isatin 16.1g (0.1mol) at 0.1: 3.0; Phenylo boric acid 48.8g (0.4mol); Copper trifluoromethanesulfcomposite 1.8g (0.005mol); One water phenanthroline 2.0g (0.01mol); Lithium Hydroxide Monohydrate 12.6g (0.3mol); Organic solvent is methylene dichloride 241.5g, and its total consumption is 15 times of N-methyl-isatin quality.
All the other are with embodiment 6, products obtained therefrom N-methyl-3-hydroxyl-3-Phenylindole-2-ketone 21.9g, yield 91%, purity 99.3%.
Embodiment 10~33:
Isatin, aryl boric acid, copper trifluoromethanesulfcomposite, a water phenanthroline, Lithium Hydroxide Monohydrate are 1.0: 4.0: 0.05 with the amount of substance ratio: the back that feeds intake added 80 ℃ of methylene dichloride heated sealed in 0.1: 3.0; Reacted 48 hours; All the other steps are with embodiment 6, and the result is as shown in the table:
Figure BDA0000093176530000081

Claims (10)

1. a structure is suc as formula the compound method of the 3-hydroxyl shown in (I)-3-(hetero) aryl indole-2-ketone derivatives; Said method comprises the following steps: that be raw material suc as formula isatin compounds shown in (II) and structure suc as formula the aryl boric acid shown in (III) with structure; Fully reaction in inert organic solvents in the presence of copper catalyst, nitrogenous bitooth ligand and basic cpd; Reaction finishes afterreaction liquid through separation and purification, obtains described 3-hydroxyl-3-Phenylindole-2-ketone derivatives; Described copper catalyst is selected from following a kind of or any several kinds combination: copper trifluoromethanesulfcomposite, acetylacetone copper, neutralized verdigris, cuprous iodide, cupric bromide, cupric fluoride, cupric chloride;
Figure FDA0000093176520000011
Formula (I), (II) or (III) in, R 1And R 2Independently be selected from one of following separately: the alkyl of hydrogen, C1~C8, the alkoxyl group of C1~C8, allyl group, benzyl, hydrocinnamyl, halogen; R 3Be selected from one of following: phenyl, naphthyl, substituted-phenyl, the substituting group of said substituted-phenyl are the alkyl of C1~C8, alkoxyl group, trifluoromethyl, halogen, nitro or the phenyl of C1~C8.
2. the compound method of 3-hydroxyl as claimed in claim 1-3-(hetero) aryl indole-2-ketone derivatives is characterized in that: described R 1For one of following: the alkyl of hydrogen, C1~C8, the alkoxyl group of C1~C8, halogen; Described R 2For one of following: the alkyl of C1~C8, allyl group, benzyl, hydrocinnamyl.
3. according to claim 1 or claim 2 the compound method of 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives; It is characterized in that: described nitrogenous bitooth ligand is selected from one of following: a water phenanthroline, 4; 7-dimethyl-phenanthroline, dipyridyl, 4,4 '-dimethyl--2,2 '-dipyridyl.
4. according to claim 1 or claim 2 the compound method of 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives, it is characterized in that: described basic cpd is selected from following a kind of or any several kinds combination: yellow soda ash, salt of wormwood, cesium carbonate, Quilonum Retard, sodium hydroxide, Pottasium Hydroxide, Lithium Hydroxide MonoHydrate, potassiumphosphate, Potassium monofluoride, Repone K, lithium fluoride, lithiumbromide, sodium-acetate, potassium tert.-butoxide, triethylamine, urotropine.
5. according to claim 1 or claim 2 the compound method of 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives; It is characterized in that: said inert organic solvents is selected from following a kind of or any several kinds combination: the alkanes of C1~C8, halogenated hydrocarbon, N; N ,-dimethylformamide class, ester class, alcohols, ethers, ketone, nitrile solvents.
6. according to claim 1 or claim 2 the compound method of 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives, it is characterized in that: described copper catalyst is copper trifluoromethanesulfcomposite or acetylacetone copper; Described nitrogenous bitooth ligand is a water phenanthroline; Described basic cpd is a Lithium Hydroxide Monohydrate; Described inert organic solvents is a methylene dichloride.
7. according to claim 1 or claim 2 the compound method of 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives, it is characterized in that: the molar ratio of said isatin compounds and aryl boric acid, copper catalyst, nitrogenous bitooth ligand and basic cpd is 1.0: 1.0~6.0: 0.01~1.0: 0.01~1.0: 1.0~5.0; The quality consumption of said inert organic solvents is 1~35 times of said isatin compounds quality.
8. according to claim 1 or claim 2 the compound method of 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives, it is characterized in that: the molar ratio of said isatin compounds, aryl boric acid, copper catalyst, nitrogenous bitooth ligand and basic cpd is 1.0: 2.0~4.0: 0.05~0.1: 0.05~0.1: 2.0~3.5; The quality consumption of said inert organic solvents is 15~25 times of said isatin compounds quality.
9. according to claim 1 or claim 2 the compound method of 3-hydroxyl-3-(hetero) aryl indole-2-ketone derivatives is characterized in that: said being reflected under 30~150 ℃ the temperature condition carried out.
10. the compound method of 3-hydroxyl as claimed in claim 9-3-(hetero) aryl indole-2-ketone derivatives is characterized in that: temperature of reaction is 45~100 ℃, and the reaction times is 24~48h.
CN 201110282142 2011-09-21 2011-09-21 Method for synthesizing 3-hydroxy-3-arylindole-2-one derivative Expired - Fee Related CN102432523B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110282142 CN102432523B (en) 2011-09-21 2011-09-21 Method for synthesizing 3-hydroxy-3-arylindole-2-one derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110282142 CN102432523B (en) 2011-09-21 2011-09-21 Method for synthesizing 3-hydroxy-3-arylindole-2-one derivative

Publications (2)

Publication Number Publication Date
CN102432523A true CN102432523A (en) 2012-05-02
CN102432523B CN102432523B (en) 2013-11-06

Family

ID=45980918

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110282142 Expired - Fee Related CN102432523B (en) 2011-09-21 2011-09-21 Method for synthesizing 3-hydroxy-3-arylindole-2-one derivative

Country Status (1)

Country Link
CN (1) CN102432523B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102952061A (en) * 2012-10-18 2013-03-06 上海大学 N-substituted indole-diketone compound and preparation method thereof
CN103342651A (en) * 2013-07-22 2013-10-09 温州大学 Synthesis method of diaryl aniline compound
CN104059012A (en) * 2014-07-02 2014-09-24 郑攀锋 Method for preparing drug intermediate benzpyrole-2,3-diketone-class compounds
CN108424380A (en) * 2018-03-05 2018-08-21 河南师范大学 A method of synthesis 3H- indoles -3- ketones derivants
CN110194733A (en) * 2019-06-25 2019-09-03 上海应用技术大学 A kind of preparation method of 3- fluoroalkyl -3-hydroxyindole ketone compound
CN112920191A (en) * 2021-01-12 2021-06-08 南宁师范大学 Arylethynyl oxindole oxirane as well as preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030171593A1 (en) * 2001-12-20 2003-09-11 Cellier Pascal Philippe Process for arylating or vinylating or alkynating a nucleophilic compound
CN1668595A (en) * 2002-05-31 2005-09-14 罗狄亚化学公司 Method of forming a carbon-carbon or carbon-heteroatom linkage
CN101503404A (en) * 2009-03-16 2009-08-12 华东师范大学 Preparation of 3-substituted-3-hydroxy-indole-2-ketone bis-heterocyclic derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030171593A1 (en) * 2001-12-20 2003-09-11 Cellier Pascal Philippe Process for arylating or vinylating or alkynating a nucleophilic compound
CN1668595A (en) * 2002-05-31 2005-09-14 罗狄亚化学公司 Method of forming a carbon-carbon or carbon-heteroatom linkage
CN101503404A (en) * 2009-03-16 2009-08-12 华东师范大学 Preparation of 3-substituted-3-hydroxy-indole-2-ketone bis-heterocyclic derivative

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
《organic Letters》 20000331 Zhen Liu,等 Catalytic Asymmetric Addition of Arylboronic Acids to Isatins using C2-Symmetric Cationic N-HeterocyclicCarbenes (NHCs) Pd2� Diaqua Complexes as Catalysts 第2314-2315页 1-10 第13卷, 第9期 *
HANMEI ZHENG,等: "Copper(II) Acetate-Catalyzed Addition ofArylboronic Acids to Aromatic Aldehydes", 《J. ORG. CHEM》 *
RYO SHINTANI,等: "Copper-catalyzed asymmetric addition of arylboronates toisatins: a catalytic cycle involving alkoxocopper intermediates", 《CHEM. COMMUN》 *
RYO SHINTANI,等: "Rhodium-Catalyzed Asymmetric Addition of Aryl- and Alkenylboronic Acids to Isatins", 《ANGEW. CHEM. INT. ED》 *
ZHEN LIU,等: "Catalytic Asymmetric Addition of Arylboronic Acids to Isatins using C2-Symmetric Cationic N-HeterocyclicCarbenes (NHCs) Pd2þ Diaqua Complexes as Catalysts", 《ORGANIC LETTERS》 *
ZHEN LIU,等: "Catalytic Asymmetric Addition of Arylboronic Acids to Isatins using C2-Symmetric Cationic N-HeterocyclicCarbenes (NHCs) Pd2þ Diaqua Complexes as Catalysts", 《ORGANIC LETTERS》, vol. 13, no. 9, 31 March 2000 (2000-03-31), pages 2314 - 2315 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102952061A (en) * 2012-10-18 2013-03-06 上海大学 N-substituted indole-diketone compound and preparation method thereof
CN102952061B (en) * 2012-10-18 2014-10-01 上海大学 N-substituted indole-diketone compound and preparation method thereof
CN103342651A (en) * 2013-07-22 2013-10-09 温州大学 Synthesis method of diaryl aniline compound
CN103342651B (en) * 2013-07-22 2014-07-02 温州大学 Synthesis method of diaryl aniline compound
CN104059012A (en) * 2014-07-02 2014-09-24 郑攀锋 Method for preparing drug intermediate benzpyrole-2,3-diketone-class compounds
CN108424380A (en) * 2018-03-05 2018-08-21 河南师范大学 A method of synthesis 3H- indoles -3- ketones derivants
CN108424380B (en) * 2018-03-05 2021-12-24 河南师范大学 Method for synthesizing 3H-indole-3-ketone derivative
CN110194733A (en) * 2019-06-25 2019-09-03 上海应用技术大学 A kind of preparation method of 3- fluoroalkyl -3-hydroxyindole ketone compound
CN110194733B (en) * 2019-06-25 2022-11-15 上海应用技术大学 Preparation method of 3-difluoroalkyl-3-hydroxyindolone compound
CN112920191A (en) * 2021-01-12 2021-06-08 南宁师范大学 Arylethynyl oxindole oxirane as well as preparation method and application thereof
CN112920191B (en) * 2021-01-12 2022-03-25 南宁师范大学 Arylethynyl oxindole oxirane as well as preparation method and application thereof

Also Published As

Publication number Publication date
CN102432523B (en) 2013-11-06

Similar Documents

Publication Publication Date Title
CN102432523B (en) Method for synthesizing 3-hydroxy-3-arylindole-2-one derivative
CN102531856B (en) Method for synthesizing asymmetric diaryl ether derivative
CN102382001B (en) Synthesis method for ortho amino aromatic formic acid aryl ester derivatives
CN102153557B (en) Chiral center nitrogen heterocyclic carbine precursor salt with quadrol skeleton, synthetic method and application
CN101333176B (en) Method for preparing substituent urea and co-producing hydrochloride of corresponding amines
CN102001979B (en) Preparation method of 2-(2', 2'-difluoroethoxyl)-6-trifluoromethyl phenyl propyl sulfide
CN111138465B (en) Synthesis method of 1-borylmethyl-6-aryl-3-benzenesulfonyl-3-azabicyclohexane derivative
CN109776407B (en) Preparation method of 2-methyl-4-hydroxymethyl quinoline and derivatives thereof
CN110105179B (en) Method for synthesizing aromatic compound by coupling nitroarene and boric acid compound under catalysis of palladium/imidazolium salt
CN109705048B (en) Clean preparation method of tebuconazole
CN114989178B (en) Spiro [ beta-lactam-3, 3' -oxindole ] derivative and preparation method and application thereof
CN102002012A (en) Method for synthesizing 1,3-oxazole-2,4-diketone compounds
CN113354655B (en) Bis-benzo [5,6] spiroketal compound and preparation method thereof
CN102153477A (en) Novel method for synthesizing chiral 4-nitryl-3, 5-diaryl cyclohexanone
CN104478799B (en) The preparation method of 1,4-diallyl isoquinolin
CN102557943A (en) Method for synthesizing aromatic formic acid aryl ester derivative
CN113004248A (en) Method for synthesizing carbazole compound by catalyzing hydrocarbon amination reaction with cobalt
CN102898340A (en) Synthesis method of S-substituted-anthranilate thioester derivatives
CN108658812B (en) Alpha-alkoxy-alpha-nitrogen oxyacetate derivative and synthesis method and application thereof
CN106946771B (en) A kind of preparation method of 3- pyridone class compound
CN108129377B (en) Method for directly synthesizing substituted 2-indolone from substituted indole under neutral condition
CN112645896A (en) Method for synthesizing 4-aryl isoxazole derivative
CN102153455B (en) Method for synthesizing multi-substituted 3-phenyl four-membered-ring ketene compounds
CN101220058B (en) Chirality and non-chirality PCN pincerlike palladium compound, synthesizing method and uses
CN102675204B (en) Intermediate for synthesizing (I)-huperzine A, synthesis method and usage thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131106

Termination date: 20180921